Your browser doesn't support javascript.
loading
Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study.
Kelley, Robin Kate; Sangro, Bruno; Harris, William; Ikeda, Masafumi; Okusaka, Takuji; Kang, Yoon-Koo; Qin, Shukui; Tai, David W-M; Lim, Ho Yeong; Yau, Thomas; Yong, Wei-Peng; Cheng, Ann-Lii; Gasbarrini, Antonio; Damian, Silvia; Bruix, Jordi; Borad, Mitesh; Bendell, Johanna; Kim, Tae-You; Standifer, Nathan; He, Philip; Makowsky, Mallory; Negro, Alejandra; Kudo, Masatoshi; Abou-Alfa, Ghassan K.
Afiliação
  • Kelley RK; University of California, San Francisco, CA.
  • Sangro B; Liver Unit, Clínica Universidad de Navarra, IdiSNA and CIBEREHD, Pamplona, Spain.
  • Harris W; University of Washington, Seattle, WA.
  • Ikeda M; National Cancer Center Hospital East, Kashiwa, Japan.
  • Okusaka T; National Cancer Center Hospital, Tokyo, Japan.
  • Kang YK; Department of Oncology, Asan Medical Center (AMC), University of Ulsan, Seoul, South Korea.
  • Qin S; Cancer Center of Nanjing, Jinling Hospital, Nanjing, China.
  • Tai DW; National Cancer Centre Singapore, Singapore.
  • Lim HY; Samsung Medical Center (SMC), Sungkyunkwan University, Seoul, South Korea.
  • Yau T; Queen Mary Hospital, Pok Fu Lam, Hong Kong.
  • Yong WP; National University Cancer Institute Singapore (NCIS), Singapore.
  • Cheng AL; National Taiwan University (NTU), Taipei, Taiwan.
  • Gasbarrini A; Catholic University of the Sacred Heart, Milan, Italy.
  • Damian S; Fondazione IRCCS Istituto Nazionale Tumori, Milano, Italy.
  • Bruix J; Barcelona Clinic Liver Cancer (BCLC), Hospital Clinic Barcelona, Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS) and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Barcelona, Spain.
  • Borad M; Mayo Clinic Cancer Center, Phoenix, AZ.
  • Bendell J; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN.
  • Kim TY; Seoul National University Hospital, Seoul, South Korea.
  • Standifer N; AstraZeneca, South San Francisco, CA.
  • He P; AstraZeneca, Gaithersburg, MD.
  • Makowsky M; AstraZeneca, Gaithersburg, MD.
  • Negro A; AstraZeneca, Gaithersburg, MD.
  • Kudo M; Faculty of Medicine, Kindai University, Osaka, Japan.
  • Abou-Alfa GK; Memorial Sloan Kettering Cancer Center, New York, NY.
J Clin Oncol ; 39(27): 2991-3001, 2021 09 20.
Article em En | MEDLINE | ID: mdl-34292792
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article